Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de Pointes

Clin Pharmacol Ther. 2018 Feb;103(2):304-309. doi: 10.1002/cpt.783. Epub 2017 Dec 8.

Abstract

Several risk factors for development of a potentially fatal ventricular arrhythmia, torsade de pointes, have been observed, including female gender. However, in most investigations, only few torsade events were included and/or rarely were postdose heart rate corrected QT (QTc) measurements included, as a surrogate of drug exposure. We developed a multivariate logistic regression model using data from 22,214 patients (33% women) with 84 torsade events (56% women) to evaluate the relationship between risk factors for torsade using data from four anti-arrhythmic drug development programs. Before model development, we evaluated different QT/QTc postdose metrics (average, maximum, etc.) to determine which QT metric should be included into the model. The developed multivariate model showed that, after accounting for known risk factors for torsade and postdose QTc, that female gender remained a significant risk factor for torsade.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Action Potentials / drug effects
  • Aged
  • Anti-Arrhythmia Agents / adverse effects*
  • Data Mining / methods
  • Databases, Factual
  • Drug Development / methods*
  • Drug Discovery / methods*
  • Evidence-Based Medicine / methods
  • Female
  • Heart Conduction System / drug effects*
  • Heart Conduction System / physiopathology
  • Heart Rate / drug effects
  • Humans
  • Male
  • Middle Aged
  • Models, Theoretical
  • Patient Safety
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Torsades de Pointes / chemically induced*
  • Torsades de Pointes / diagnosis
  • Torsades de Pointes / physiopathology

Substances

  • Anti-Arrhythmia Agents